Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Cystitis: symptomatology in women with suspected uncomplicated urinary tract infection.

Heytens S, De Sutter A, De Backer D, Verschraegen G, Christiaens T.

J Womens Health (Larchmt). 2011 Jul;20(7):1117-21. doi: 10.1089/jwh.2010.2302. Epub 2011 Jun 14.

PMID:
21671766
2.

Speed of molecular detection techniques for methicillin-resistant Staphylococcus aureus admission screening in an acute care hospital.

Floré K, Van den Abeele AM, Verschraegen G.

J Hosp Infect. 2010 Jun;75(2):103-6. doi: 10.1016/j.jhin.2010.02.023. Epub 2010 Apr 10.

PMID:
20381915
3.

Replacement of administration sets used to administer blood, blood products, or lipid emulsions for the prevention of central line-associated bloodstream infection.

Labeau S, Vandijck D, Lizy C, Piette A, Verschraegen G, Vogelaers D, Blot S.

Infect Control Hosp Epidemiol. 2009 May;30(5):494. doi: 10.1086/596607. No abstract available.

PMID:
19344267
4.

Destructive otomastoiditis by MRSA from porcine origin.

Van Hoecke H, Piette A, De Leenheer E, Lagasse N, Struelens M, Verschraegen G, Dhooge I.

Laryngoscope. 2009 Jan;119(1):137-40. doi: 10.1002/lary.20030.

PMID:
19117307
5.

Role of coagulase-negative staphylococci in human disease.

Piette A, Verschraegen G.

Vet Microbiol. 2009 Feb 16;134(1-2):45-54. doi: 10.1016/j.vetmic.2008.09.009. Epub 2008 Sep 11.

PMID:
18986783
6.

Evolution of bacterial susceptibility pattern of Escherichia coli in uncomplicated urinary tract infections in a country with high antibiotic consumption: a comparison of two surveys with a 10 year interval.

De Backer D, Christiaens T, Heytens S, De Sutter A, Stobberingh EE, Verschraegen G.

J Antimicrob Chemother. 2008 Aug;62(2):364-8. doi: 10.1093/jac/dkn197. Epub 2008 May 22.

PMID:
18499768
7.

Costs and length of stay associated with antimicrobial resistance in acute kidney injury patients with bloodstream infection.

Vandijck DM, Blot SI, Decruyenaere JM, Vanholder RC, De Waele JJ, Lameire NH, Claus S, De Schuijmer J, Dhondt AW, Verschraegen G, Hoste EA.

Acta Clin Belg. 2008 Jan-Feb;63(1):31-8.

PMID:
18386763
8.

Systematic surveillance cultures as a tool to predict involvement of multidrug antibiotic resistant bacteria in ventilator-associated pneumonia.

Depuydt P, Benoit D, Vogelaers D, Decruyenaere J, Vandijck D, Claeys G, Verschraegen G, Blot S.

Intensive Care Med. 2008 Apr;34(4):675-82. Epub 2007 Dec 8.

PMID:
18066522
9.

Health implications of antimicrobial resistance for patients with acute kidney injury and bloodstream infection.

Hoste EA, Vandijck DM, Vanholder RC, De Waele JJ, Lameire NH, Claus S, De Schuijmer J, Dhondt AW, Decruyenaere JM, Verschraegen G, Blot SI.

Infect Control Hosp Epidemiol. 2007 Sep;28(9):1107-10. Epub 2007 Jul 12.

PMID:
17932837
10.

Infection risk related to the use of medicinal leeches.

Bauters TG, Buyle FM, Verschraegen G, Vermis K, Vogelaers D, Claeys G, Robays H.

Pharm World Sci. 2007 Jun;29(3):122-5. Epub 2007 Mar 13.

PMID:
17353971
11.
12.

Streptococcus cristatus isolated from a resected heart valve and blood cultures: case reports and application of phenotypic and genotypic techniques for identification.

Matthys C, Claeys G, Verschraegen G, Wauters G, Vogelaers D, De Baere T, Verhelst R, Van Nooten G, Van Coster R, Vaneechoutte M.

Acta Clin Belg. 2006 Jul-Aug;61(4):196-200.

PMID:
17091918
13.

Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures.

Depuydt P, Benoit D, Vogelaers D, Claeys G, Verschraegen G, Vandewoude K, Decruyenaere J, Blot S.

Intensive Care Med. 2006 Nov;32(11):1773-81. Epub 2006 Sep 16.

PMID:
16983549
14.

Antibiotic susceptibility of Atopobium vaginae.

De Backer E, Verhelst R, Verstraelen H, Claeys G, Verschraegen G, Temmerman M, Vaneechoutte M.

BMC Infect Dis. 2006 Mar 16;6:51.

15.

Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit.

Depuydt PO, Blot SI, Benoit DD, Claeys GW, Verschraegen GL, Vandewoude KH, Vogelaers DP, Decruyenaere JM, Colardyn FA.

Crit Care Med. 2006 Mar;34(3):653-9.

PMID:
16505649
16.

Comparison between Gram stain and culture for the characterization of vaginal microflora: definition of a distinct grade that resembles grade I microflora and revised categorization of grade I microflora.

Verhelst R, Verstraelen H, Claeys G, Verschraegen G, Van Simaey L, De Ganck C, De Backer E, Temmerman M, Vaneechoutte M.

BMC Microbiol. 2005 Oct 14;5:61.

17.

Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in an intensive care unit.

Blot S, Depuydt P, Vogelaers D, Decruyenaere J, De Waele J, Hoste E, Peleman R, Claeys G, Verschraegen G, Colardyn F, Vandewoude K.

Infect Control Hosp Epidemiol. 2005 Jun;26(6):575-9.

PMID:
16018434
18.

Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center.

Van Daele S, Verhelst R, Claeys G, Verschraegen G, Franckx H, Van Simaey L, de Ganck C, De Baets F, Vaneechoutte M.

J Clin Microbiol. 2005 Jun;43(6):2998-3002.

19.

Prevalence of Helicobacter pullorum among patients with gastrointestinal disease and clinically healthy persons.

Ceelen L, Decostere A, Verschraegen G, Ducatelle R, Haesebrouck F.

J Clin Microbiol. 2005 Jun;43(6):2984-6.

20.

An interlaboratory comparison of ITS2-PCR for the identification of yeasts, using the ABI Prism 310 and CEQ8000 capillary electrophoresis systems.

De Baere T, Van Keerberghen A, Van Hauwe P, De Beenhouwer H, Boel A, Verschraegen G, Claeys G, Vaneechoutte M.

BMC Microbiol. 2005 Mar 18;5:14.

21.

Extended-Spectrum beta-lactamase (ESBL) producing Enterobacter aerogenes phenotypically misidentified as Klebsiella pneumoniae or K. terrigena.

Claeys G, De Baere T, Wauters G, Vandecandelaere P, Verschraegen G, Muylaert A, Vaneechoutte M.

BMC Microbiol. 2004 Dec 24;4:49.

22.

Bacteremic infection with Pantoea ananatis.

De Baere T, Verhelst R, Labit C, Verschraegen G, Wauters G, Claeys G, Vaneechoutte M.

J Clin Microbiol. 2004 Sep;42(9):4393-5.

23.

Antibiotic susceptibility of acute otitis media pathogens in otitis-prone Belgian children.

van Kempen MJ, Vaneechoutte M, Claeys G, Verschraegen GL, Vermeiren J, Dhooge IJ.

Eur J Pediatr. 2004 Sep;163(9):524-9. Epub 2004 Jun 15.

PMID:
15322870
24.

Towards a Belgian consensus for prevention of perinatal group B streptococcal disease.

Melin P, Verschraegen G, Mahieu L, Claeys G, Mol PD.

Indian J Med Res. 2004 May;119 Suppl:197-200.

PMID:
15232194
25.

Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis.

Verhelst R, Verstraelen H, Claeys G, Verschraegen G, Delanghe J, Van Simaey L, De Ganck C, Temmerman M, Vaneechoutte M.

BMC Microbiol. 2004 Apr 21;4:16.

26.
27.

Ten years phage-typing of Belgian clinical methicillin-resistant Staphylococcus aureus isolates (1992-2001).

Wildemauwe C, Godard C, Verschraegen G, Claeys G, Duyck MC, De Beenhouwer H, Vanhoof R.

J Hosp Infect. 2004 Jan;56(1):16-21.

PMID:
14706266
28.

Beta-casein-derived peptides, produced by bacteria, stimulate cancer cell invasion and motility.

Oliveira MJ, Van Damme J, Lauwaet T, De Corte V, De Bruyne G, Verschraegen G, Vaneechoutte M, Goethals M, Ahmadian MR, Müller O, Vandekerckhove J, Mareel M, Leroy A.

EMBO J. 2003 Nov 17;22(22):6161-73.

29.

Urinary infections in patients with spinal cord injury.

Penders J, Huylenbroeck AA, Everaert K, Van Laere M, Verschraegen GL.

Spinal Cord. 2003 Oct;41(10):549-52.

PMID:
14504611
30.

Comparison of five genotypic techniques for identification of optochin-resistant pneumococcus-like isolates.

Verhelst R, Kaijalainen T, De Baere T, Verschraegen G, Claeys G, Van Simaey L, De Ganck C, Vaneechoutte M.

J Clin Microbiol. 2003 Aug;41(8):3521-5.

31.

Isolation of Buttiauxella gaviniae from a spinal cord patient with urinary bladder pathology.

De Baere T, Wauters G, Kämpfer P, Labit C, Claeys G, Verschraegen G, Vaneechoutte M.

J Clin Microbiol. 2002 Oct;40(10):3867-70.

32.

Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women.

Christiaens TC, De Meyere M, Verschraegen G, Peersman W, Heytens S, De Maeseneer JM.

Br J Gen Pract. 2002 Sep;52(482):729-34.

33.
34.

Bacteremia due to Moraxella atlantae in a cancer patient.

De Baere T, Muylaert A, Everaert E, Wauters G, Claeys G, Verschraegen G, Vaneechoutte M.

J Clin Microbiol. 2002 Jul;40(7):2693-5.

35.

Study of the intra- and interlaboratory reproducibility of partial single base C-sequencing of the 16S rRNA gene and its applicability for the identification of members of the genus Streptococcus.

Storms V, Baele M, Coopman R, Willems A, de Baere T, Haesebrouck F, Verschraegen G, Gillis M, Vaneechoutte M.

Syst Appl Microbiol. 2002 Apr;25(1):52-9.

PMID:
12086189
36.

Evaluation of amplified rDNA restriction analysis (ARDRA) for the identification of cultured mycobacteria in a diagnostic laboratory.

De Baere T, de Mendonça R, Claeys G, Verschraegen G, Mijs W, Verhelst R, Rottiers S, Van Simaey L, De Ganck C, Vaneechoutte M.

BMC Microbiol. 2002 Mar 1;2:4.

37.

Susceptibility testing of fluconazole by the NCCLS broth macrodilution method, E-test, and disk diffusion for application in the routine laboratory.

Vandenbossche I, Vaneechoutte M, Vandevenne M, De Baere T, Verschraegen G.

J Clin Microbiol. 2002 Mar;40(3):918-21.

38.

Problems in diagnosis and treatment of Staphylococcus haemolyticus endocarditis in a hemodialysis patient.

Louagie H, Struelens M, De Ryck R, Claeys G, Verschraegen G, Vogelaers D, Lameire N, Vaneechoutte M.

Clin Microbiol Infect. 1998 Jan;4(1):44-48. No abstract available.

39.

Role of nasopharyngeal bacterial flora in the evaluation of recurrent middle ear infections in children.

Dhooge I, Van Damme D, Vaneechoutte M, Claeys G, Verschraegen G, Van Cauwenberge P.

Clin Microbiol Infect. 1999 Sep;5(9):530-534.

40.

Identification of a new biotype of Actinomyces hyovaginalis in tissues of pigs during diagnostic bacteriological examination.

Storms V, Hommez J, Devriese LA, Vaneechoutte M, De Baere T, Baele M, Coopman R, Verschraegen G, Gillis M, Haesebrouck F.

Vet Microbiol. 2002 Jan 3;84(1-2):93-102.

PMID:
11731162
41.

One case each of recurrent meningitis and hemoperitoneum infection with Ralstonia mannitolilytica.

Vaneechoutte M, De Baere T, Wauters G, Steyaert S, Claeys G, Vogelaers D, Verschraegen G.

J Clin Microbiol. 2001 Dec;39(12):4588-90.

42.

Case of catheter sepsis with Ralstonia gilardii in a child with acute lymphoblastic leukemia.

Wauters G, Claeys G, Verschraegen G, De Baere T, Vandecruys E, Van Simaey L, De Ganck C, Vaneechoutte M.

J Clin Microbiol. 2001 Dec;39(12):4583-4.

43.

Methicillin resistance of bacteria isolated from vitreous fluid from patients undergoing vitrectomy.

Labit CM, Claeys GW, Verbraeken HE, Verschraegen GL.

Eur J Ophthalmol. 2001 Apr-Jun;11(2):160-5.

PMID:
11456018
44.

Classification of Ralstonia pickettii biovar 3/'thomasii' strains (Pickett 1994) and of new isolates related to nosocomial recurrent meningitis as Ralstonia mannitolytica sp. nov.

De Baere T, Steyaert S, Wauters G, Des Vos P, Goris J, Coenye T, Suyama T, Verschraegen G, Vaneechoutte M.

Int J Syst Evol Microbiol. 2001 Mar;51(Pt 2):547-58.

PMID:
11321101
45.

[Avoidable "fever of unknown origin" due to Ralstonia pickettii bacteremia].

T'Sjoen G, Verschraegen G, Steyaert S, Vogelaers D.

Acta Clin Belg. 2001 Jan-Feb;56(1):51-4. Dutch.

PMID:
11307484
46.

Evaluation of six commercial assays for the rapid detection of Clostridium difficile toxin and/or antigen in stool specimens.

Vanpoucke H, De Baere T, Claeys G, Vaneechoutte M, Verschraegen G.

Clin Microbiol Infect. 2001 Feb;7(2):55-64.

47.

Modified Granada Agar Medium for the detection of group B Streptococcus carriage in pregnant women.

Claeys G, Verschraegen G, Temmerman M.

Clin Microbiol Infect. 2001 Jan;7(1):22-4.

48.

Isolations of Leclercia adecarboxylata from a patient with a chronically inflamed gallbladder and from a patient with sepsis without focus.

de Baere T, Wauters G, Huylenbroeck A, Claeys G, Peleman R, Verschraegen G, Allemeersch D, Vaneechoutte M.

J Clin Microbiol. 2001 Apr;39(4):1674-5.

49.

Application and evaluation of the interlaboratory reproducibility of tRNA intergenic length polymorphism analysis (tDNA-PCR) for identification of Streptococcus species.

Baele M, Storms V, Haesebrouck F, Devriese LA, Gillis M, Verschraegen G, de Baere T, Vaneechoutte M.

J Clin Microbiol. 2001 Apr;39(4):1436-42.

50.

Mycobacterium interjectum as causative agent of cervical lymphadenitis.

De Baere T, Moerman M, Rigouts L, Dhooge C, Vermeersch H, Verschraegen G, Vaneechoutte M.

J Clin Microbiol. 2001 Feb;39(2):725-7. Review.

Supplemental Content

Loading ...
Support Center